Ian Nicholson (53)
Appointed to the Board
13 June 2012
Ian is also Chief Executive Officer of F2G Ltd, a UK-based anti-fungal drug discovery and development company, Chairman of Bioventix Ltd, a diagnostics company, non-executive director of Clinigen Group plc, a specialty pharmaceuticals and services business, and also an Operating Partner at Advent Life Sciences LLP.
Mr Nicholson is Chair of the Corporate Responsibility Committee and a member of the Nomination Committee.
Past Roles & Experience
From 2004 to 2012 Ian was Chief Executive of Chroma Therapeutics Limited, a drug discovery and development company and from 2000 to 2004 Senior Vice President, Business Development at Celltech Group plc, then the UK's largest biotechnology company.
In addition to his CEO experience Mr Nicholson has extensive experience in business development, licensing and mergers and acquisitions in the UK, Europe and the US.